OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AIM$2.6656

Aimia Inc

Specialty ChemicalsVerified

Aimia Inc has a market price of $2.66 per share and a market capitalization of $236.8 million. The company's price-to-book ratio is 0.75, and its enterprise value to EBITDA is 15.45, indicating a relatively low valuation compared to its book value and earnings. The company's debt-to-equity ratio is 0.96, suggesting a moderate level of leverage, while its current ratio of 2.89 indicates strong short-term liquidity. In terms of profitability, Aimia Inc reported a net loss of $16.2 million and an operating income of $27.8 million in the latest period. The company's return on equity is -5.16%, and its return on assets is -1.94%, both of which are below the industry median for specialty chemicals. The gross profit margin is 27.1%, which is in line with the industry average, but the net loss indicates significant cost pressures or operational inefficiencies. Aimia Inc's revenue is primarily concentrated in its core chemical production and distribution segments, with no disclosed geographic diversification in the latest financial data. The company's capital expenditures were -$16.7 million, indicating a reduction in investment in physical assets, which may reflect a strategic shift or financial constraints. Looking ahead, Aimia Inc's revenue outlook is uncertain, with no specific guidance provided in the latest financial data. The company's free cash flow is $1.9 million, which is significantly lower than its operating cash flow of $56.1 million, suggesting that capital expenditures are consuming a large portion of its operating cash flow. The company's liquidity is assessed as medium, and its dilution risk is low, although net cash is negative after subtracting total debt. Recent events and filings do not indicate any major strategic shifts or significant operational changes for Aimia Inc in the latest period. The company's financial performance and strategic direction appear to be stable, but the net loss and negative return on equity suggest that management may need to address cost structures or revenue diversification to improve profitability.

30-day price · AIM-0.26 (-51.1%)
Low$0.21High$0.69Close$0.25As of20 May, 00:00 UTC
Profile
CompanyAimia Inc
TickerAIM.TO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Aimia Inc is a specialty chemicals company that produces and distributes chemical products for industrial and consumer applications.

Classification. Aimia Inc is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Aimia Inc has a market price of $2.66 per share and a market capitalization of $236.8 million. The company's price-to-book ratio is 0.75, and its enterprise value to EBITDA is 15.45, indicating a relatively low valuation compared to its book value and earnings. The company's debt-to-equity ratio is 0.96, suggesting a moderate level of leverage, while its current ratio of 2.89 indicates strong short-term liquidity. In terms of profitability, Aimia Inc reported a net loss of $16.2 million and an operating income of $27.8 million in the latest period. The company's return on equity is -5.16%, and its return on assets is -1.94%, both of which are below the industry median for specialty chemicals. The gross profit margin is 27.1%, which is in line with the industry average, but the net loss indicates significant cost pressures or operational inefficiencies. Aimia Inc's revenue is primarily concentrated in its core chemical production and distribution segments, with no disclosed geographic diversification in the latest financial data. The company's capital expenditures were -$16.7 million, indicating a reduction in investment in physical assets, which may reflect a strategic shift or financial constraints. Looking ahead, Aimia Inc's revenue outlook is uncertain, with no specific guidance provided in the latest financial data. The company's free cash flow is $1.9 million, which is significantly lower than its operating cash flow of $56.1 million, suggesting that capital expenditures are consuming a large portion of its operating cash flow. The company's liquidity is assessed as medium, and its dilution risk is low, although net cash is negative after subtracting total debt. Recent events and filings do not indicate any major strategic shifts or significant operational changes for Aimia Inc in the latest period. The company's financial performance and strategic direction appear to be stable, but the net loss and negative return on equity suggest that management may need to address cost structures or revenue diversification to improve profitability.
Key takeaways
  • Aimia Inc has a market price of $2.66 and a market capitalization of $236.8 million, with a price-to-book ratio of 0.75.
  • The company reported a net loss of $16.2 million and an operating income of $27.8 million, with a return on equity of -5.16%.
  • Aimia Inc's capital expenditures were -$16.7 million, indicating a reduction in investment in physical assets.
  • The company's liquidity is assessed as medium, and its dilution risk is low, although net cash is negative after subtracting total debt.
  • Recent events and filings do not indicate any major strategic shifts or significant operational changes for Aimia Inc.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue$503.4M
Gross profit$136.3M
Operating income$27.8M
Net income-$16.2M
R&D
SG&A
D&A
SBC
Operating cash flow$56.1M
CapEx-$16.7M
Free cash flow$1.9M
Total assets$834.9M
Total liabilities$520.9M
Total equity$314.0M
Cash & equivalents$109.2M
Long-term debt$302.0M
Valuation
Market price$2.66
Market cap$236.8M
Enterprise value$429.6M
P/E
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income15.4
EV/OCF7.7
P/B0.8
P/Tangible book0.8
Tangible book$314.0M
Net cash-$192.8M
Current ratio2.9
Debt/Equity1.0
ROA-1.9%
ROE-5.2%
Cash conversion-3.5%
CapEx/Revenue-3.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricAIMActivity
Op margin5.5%5.5% medp25 -0.0% · p75 10.8%below median
Net margin-3.2%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin27.1%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-3.3%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity96.0%37.1% medp25 10.3% · p75 82.0%top quartile
Observations
IR observations
Last actual revenue503,400,000 CAD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 15:48 UTC#ff515393
Market quoteclose CAD 2.68 · shares 0.09B diluted
no public URL
2026-05-15 15:50 UTC#2494e362
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 07:22 UTCJob: 5ae6fc9b